Table 3.
HIA titers and percent A/H3N2/Aichi virus neutralization and AH1N1 PR8 virus cross-neutralization in DRAGA female and male mice sublethally (LD50)-infected with A/Aichi H3N2 virions (as per Figure 7).
| DRAGA mice # | dpi | M1 | M2 | M3 | M4 | M5 | F1 | F2 | F3 | F4 | F5 | Human sera |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| HIA titer to Aichi virus | 10 | 1:20 | 1:20 | 1:20 | 1:20 | 1:20 | 1:320** | |||||
| 16 | 1:40 | 1:40 | 1:40 | 1:120* | 1:120* | |||||||
| Percent of Aichi virus neutralization | 10 | 16 | 16 | 16 | 16 | 16 | ||||||
| 16 | 33 | 33 | 33 | 100 | 100 | |||||||
| HIA titer to PR8 virus | 10 | 1:20 | 1:40 | 1:20 | 1:20 | 1:20 | 1:560** | |||||
| 16 | 1:40 | 1:40 | 1:40 | 1:60* | 1:60* | |||||||
| Percent of PR8 virus cross-neutralization | 10 | 33 | 66 | 33 | 33 | 33 | ||||||
| 16 | 66 | 66 | 66 | 100 | 100 |
M1-M5, male mice assessed at 10 dpi, and F1-F5 female mice assessed at 16 dpi. * Highest HIA titer to Aichi virus, and, respectively, to PR8 virus among all mice in each group. Percent viral neutralization and cross-neutralization among individual mice was calculated based on the highest HIA titer to AICHI, or the highest HIA titer to PR8 viruses at 10 dpi for male mice, and, respectively, 16 dpi for female mice. ** HIA titers of a vaccinated individual with 2014 AFLUVIA vaccine and assessed in 2015.